Pfizer Ltd

• 

  Pfizer Names Meenakshi Nevatia As Managing Director

  Drug maker Pfizer Ltd on Thursday said it has appointed Meenakshi Nevatia as managing director for a period of five years with effect from April 3, 2023.

• 

  Just Dial, Pfizer To Be Dropped From BSE 200; Muthoot Finance In

  The changes are announced by Asia Index, a joint venture between S&P Dow Jones Indices LLC and BSE.

• 

  Court Asks Pfizer To Withdraw Drug 6 Months Before Expiry

  The Delhi High Court has asked pharmaceuticals major Pfizer Ltd to withdraw stocks of its already imported drug Medrol, used to treat a wide range of inflammatory, allergic and immune disorders, six months before the expiry period of 60 months prescribed under the rules.

• 

  Advent, Baxter Set To Submit Bids For India's Gland Pharma: Report

  Global buyout firm Advent International and U.S.-based Baxter International are among suitors preparing to submit separate bids to buy unlisted Indian drugmaker Gland Pharma Ltd, three people with direct knowledge of the matter told Reuters.

• Pfizer to Close Plant at Thane

  Drug firm Pfizer on Wednesday said it is closing from September 16 its over 50-year-old plant at Thane that was lying idle since 2013.

• Pfizer Falls on Weak Fourth Quarter Numbers

  Pfizer's net profit fell 24 per cent to Rs 42.7 crore from Rs 56 crore during the same period last year.

• Pfizer Posts Rs 18 Crore Profit in Q3

  It had posted a net profit of Rs 47.60 crore for the October-December quarter of 2013-14 fiscal, Pfizer Ltd said in a filing to the BSE.

• Pfizer Announces Completion of Merger With Wyeth

  Drug major Pfizer on Monday announced completion of its merger with Wyeth Ltd, thereby placing itself among the top ten pharmaceutical companies in India by market share.

• Lupin Gets Regulatory Nod to Market Arthritis Treatment Drug in US

  Drug firm Lupin Ltd on Monday said it has received approval from the US Food and Drugs Administration (FDA) to market a generic version of GD Searle LLC's Celebrex capsules, used to treat arthritis, in the American market.

• 

  Pfizer Gets Bombay High Court Nod for Merger of Wyeth

  Drug firm Pfizer Inc on Friday said the Bombay High Court has approved the amalgamation of Wyeth Ltd with the company.

• 

  Pfizer, Ranbaxy Win Dismissal of Lawsuit Over Generic Lipitor

  US District Judge Peter Sheridan in Trenton, New Jersey, ruled that the plaintiffs, retailers and distribution companies that bought Lipitor directly from Pfizer, failed to plead their case with enough detail.

• 

  Pfizer Says Threats to Managers Force Staff Lockout at Mumbai Factory

  The lockout at the Thane plant, which employs 212 people, would have no impact on the group's supply of medicines, a Pfizer Ltd spokesman said in a statement emailed to Reuters.

• Pfizer Q1 Net Dips 3 Per Cent to Rs 46 Crore

  Drug firm Pfizer on Thursday reported a 3.10 per cent decline in net profit at Rs 46.15 crore for the first quarter that ended on June 30, 2014.

• Wockhardt denies media report on asset sale talks

  Generic drugmaker Wockhardt Ltd denied on Tuesday a media report that said U.S. drugmakers Mylan Inc and Pfizer Inc were in talks with the company to buy some of its assets.

• Ranbaxy shares fall 4% after US drug recall

  Ranbaxy confirmed the recall of select batches of the drug, a generic version of Pfizer Inc's Lipitor, but said the company had not received any product complaints.